Stunnox Details

STUNNOX Logo Abridged Prescribing Information:

Composition: Each Vial Contains Botulinium Toxin 50 Units/100 Units

Indications & Dosage: Glabellar lines seen at maximum frown: 4 Units is administered in each of the 5 injection sites: 2 injections in each corrugator muscle and 1 injection in the procerus muscle for a total dose of 20 Units, Crow’s feet lines seen at maximum smile: 4 Units is administered in each of the 3 injection sites per side (total of 6 injection sites) in the lateral orbicularis oculi muscle, for a total dose of 24 Units in a total volume of 0.6 ml (12 Units per side), Forehead Lines seen at maximum eyebrow elevation, 4 Units) is administered in each of the 5 injection sites in the frontalis muscle, for a total dose of 20 Units, Primary hyperhidrosis of the axillae – 50 Units of botulinum toxin is injected intradermally to each axilla, evenly distributed in multiple sites approximately 1-2 cm apart.

Route of Administration: Intramuscular, Intradermal

Contraindications:  Known hypersensitivity to botulinum toxin type A or to any of the excipients, presence of infection at the proposed injection site(s).

Adverse effects: Localised pain, inflammation, paraesthesia, hypoaesthesia, tenderness, swelling/oedema, erythema, localised infection, bleeding and/or bruising have been associated with the injection,

Reconstitution: Reconstituted solution should be clear, colorless, and free of particulate matter.